PMA device
Inspire® Upper Airway Stimulation
Inspire Medical Systems · Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ, Class III) · First FDA decision Jun 2, 2016, newest Oct 22, 2025Sleep apnea
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
11
PMA pathway
Device trials
287
Naming "Upper Airway"
MAUDE reports
33
Brand "Upper Airway", since 2015
PubMed studies
19,473
Mentioning "Upper Airway"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Inspire® Upper Airway Stimulation
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 11 decisions filed under this name.
- Inspire® Upper Airway StimulationPMA supplement
P130008-S130 · Decided Oct 22, 2025 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
- Inspire Upper Airway Stimulation (UAS) SystemPMA supplement
P130008-S098 · Decided Aug 1, 2024 · 398 days after receipt · Normal 180 Day Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
- Inspire® Upper Airway Stimulation SystemPMA supplement
P130008-S096 · Decided May 19, 2023 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
3 more FDA decisions with a free account
Older decisions: P130008-S052, P130008-S039, P130008-S029, P130008-S016, P130008-S009
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38387Wellpoint FederalUpdated Jul 14, 2026
- Hypoglossal Nerve Stimulation for Obstructive Sleep ApneaLocal determinationIn effectL38276Palmetto GBAUpdated May 8, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38528WPS Insurance CorporationUpdated Mar 20, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38307CGS Administrators, LLCUpdated Feb 27, 2026
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38310Noridian Healthcare Solutions, LLCUpdated Oct 16, 2025
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38398First Coast Service Options, Inc.Updated Jan 24, 2020
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38385Novitas Solutions, Inc.Updated Jan 24, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Upper Airway", any status and sponsor, newest update first.
- CPAP vs High-Flow Nasal Cannula for Treating Sleep Apnea in ChildrenPivotal-lookingRecruiting
The Hospital for Sick ChildrenAcademic, hospital or other
NCT07600333 · 258 participants (planned) · Start May 27, 2026 · Primary completion Nov 2031
Device: High Flow Nasal Cannula; Continuous Positive Airway Pressure · For: Obstructive Sleep Apnea (OSA)
Sites: Toronto, Canada
- EMST 150 Training in Mild-Moderate OSANot yet recruiting
University Hospitals Cleveland Medical CenterAcademic, hospital or other
NCT07942636 · 20 participants (planned) · Start Dec 1, 2026 · Primary completion Dec 1, 2027
Device: Expiratory Muscle Strength Training Device (EMST 150) · For: Obstructive Sleep Apnea
Sites: Cleveland, Ohio
- AI-Integrated 3D-Printed Videolaryngoscope for Orotracheal Intubation in Critically Ill PatientsPivotal-lookingNot yet recruiting
Federal University of PelotasAcademic, hospital or other
NCT07592702 · 120 participants (planned) · Start Mar 20, 2027 · Primary completion Dec 2027
Device: Orotracheal intubation using a 3D videolaryngoscope integrated with artificial intelligence (VL-IA).; Commercially available gold-standard videolaryngoscope (VL-C) · For: Orotracheal Intubation
Sites: Pelotas, Brazil; Rio Grande, Brazil; Florianópolis, Brazil · 4 sites in all
284 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Upper Airway", and for the whole product code for context.
This brand
33 reports: 4 malfunction, 29 injury, 0 death
Whole product code MNQ
3,753 reports: 165 malfunction, 3,581 injury, 4 death
Newest reports for this brand
MW5185240 · Received Mar 16, 2026 · Event dated Jun 27, 2023
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Patient problem as coded: Dysphasia; Discomfort; Inappropriate Device Stimulation of Tissue
MW5182948 · Received Jan 28, 2026 · Event dated Mar 12, 2024
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MW5182590 · Received Jan 21, 2026 · Event dated Jan 3, 2026
Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Patient problem as coded: Chest Pain; Fever; Hemorrhage/Blood Loss/Bleeding; Pain; Discomfort; Sleep Dysfunction
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2515-2026 · Started May 11, 2026 · Posted by FDA Jun 18, 2026
Reason given: Products are labeled with incorrect Use By Date, extending beyond the validated three-year shelf life from date of manufacturer. Material degradation of a product past its Use By Date may result in unplanned or premature revision surgery.
Cause as FDA categorized it: Process control · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Z-2516-2026 · Started May 11, 2026 · Posted by FDA Jun 18, 2026
Reason given: Products are labeled with incorrect Use By Date, extending beyond the validated three-year shelf life from date of manufacturer. Material degradation of a product past its Use By Date may result in unplanned or premature revision surgery.
Cause as FDA categorized it: Process control · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Z-2969-2018 · Started Jun 12, 2018
Reason given: Incorrect use-by date on the device registration/patient file labels.
Cause as FDA categorized it: Error in labeling · Device type: Stimulator, Hypoglossal Nerve, Implanted, Apnea (MNQ)
Published research
The most relevant PubMed records for "Upper Airway"[tiab]. The summary above synthesizes these.
- Mini-symposium: Upper Airway Anomalies.
Tapia IE · Paediatr Respir Rev · 2016Editorial, Introductory Journal Article
- Upper airway obstruction.
Virbalas J, Smith L · Pediatr Rev · 2015Review
- Upper-airway resistance syndrome.
Guilleminault C, Los Reyes VD · Handb Clin Neurol · 2011Review
- Upper airway obstruction.
Eber E · Paediatr Respir Rev · 2004Editorial
- Upper airway reflexes.
Drummond GB · Br J Anaesth · 1993Editorial
- Acute Upper Airway Obstruction.
Lama TT, Berra L · N Engl J Med · 2020Letter, Comment
- Acute Upper Airway Obstruction.
Cannon JW, Gurney JM, Shackelford SA · N Engl J Med · 2020Letter, Comment
- Acute Upper Airway Obstruction.
Schechtman SA, Healy DW, Abdelmalak B · N Engl J Med · 2020Letter, Comment
- Acute Upper Airway Obstruction.
Eskander A, de Almeida JR, Irish JC · N Engl J Med · 2019Review
- Upper airway obstruction.
Lahiri K · Indian J Pediatr · 1996Review
- Evolving management of upper airway diseases: focus on Asia.
Zhang L · Int Forum Allergy Rhinol · 2019Editorial, Introductory Journal Article
- Upper Airway Stimulation/Hypoglossal Nerve Stimulator.
Manchanda S, Neupane P, Sigua NL · Am J Respir Crit Care Med · 2020
Other devices of this type
Also filed under product code MNQ.
- Inspire II Upper Airway StimulatorInspire Medical Systems · PMA 2026
- aura6000 systemLivaNova USA, Inc. · PMA 2026
- Genio® System 2.1Nyxoah S.A. · PMA 2025
- Inspire UAS High AHI/High BMIInspire Medical Systems · PMA 2023
- SleepSync ProgrammerInspire Medical Systems · PMA 2023
- Silicone Stimulation Lead, Silicone Sensing LeadInspire Medical Systems · PMA 2022
- Inspire Medical Systems, Model 2580 Patient ProgrammerInspire Medical Systems · PMA 2021
- Inspire Programmer SystemInspire Medical Systems · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.